Researchers at Brigham & Women's Hospital have been exploring the links between the immune system and Alzheimer's, looking for new insights that could help guide drug development. They zeroed in on a link between genetic risk factors for the disease and a particular immune cell, concluding that high levels of TREM2 are associated with higher risk. Release